Spaverin - MEDITOP

SPAVERIN tablets available in Switzerland from January

MEDITOP Switzerland A.G., the Swiss subsidiary of MEDITOP Pharmaceuticals Ltd., starts marketing activities of SPAVERIN tablets in Switzerland in January.

In several European countries, drotaverine-containing products have been one of the most effective therapies for the treatment of smooth muscle spasms for decades.

Our company has successfully registered the Spaverin tablet and drotaverine therapy is now available to patients in Switzerland.